Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3481]

First randomised evidence for kinase inhibitor activity in acute myeloid...

Dr Gerhard Ehninger - University Hospital Dresden, Dresden, Germany

First randomised evidence for kinase inhibitor activity in acute myeloid leukaemia ( Dr Gerhard Ehninger - University Hospital Dresden, Dresden, Germany )

Does the patient with myelofibrosis feel better through pacritinib?

Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA

Does the patient with myelofibrosis feel better through pacritinib? ( Dr Ruben Mesa - Mayo Clinic Cancer Center, Scottsdale, USA )

Adding elotuzumab to standard treatment for multiple myeloma significantly...

Dr Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens...

Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease progression ( Dr Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )

Treatment and survival of patients with chronic myeloid leukaemia in Europe

Dr Verena Hoffmann - Ludwig-Maximilians-Universität, München, Germany

Treatment and survival of patients with chronic myeloid leukaemia in Europe ( Dr Verena Hoffmann - Ludwig-Maximilians-Universität, München, Germany )

PM1183 plus doxorubicin shows interesting activity in small cell lung cancer

Dr Emiliano Calvo - START Madrid, Madrid, Spain

PM1183 plus doxorubicin shows interesting activity in small cell lung cancer ( Dr Emiliano Calvo - START Madrid, Madrid, Spain )

Lenvatinib increases progression free survival when used with everolimus in...

Dr James Larkin - Royal Marsden Hospital, London, UK

Lenvatinib increases progression free survival when used with everolimus in metastatic renal cell carcinoma ( Dr James Larkin - Royal Marsden Hospital, London, UK )

Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer

Dr Simon Chowdhury - Guy's Hospital, London, UK

Enzalutamide preferable to bicalutamide plus LHRH analogue in prostate cancer ( Dr Simon Chowdhury - Guy's Hospital, London, UK )

Screening to identify unsuitable candidates for ipilimumab in advanced melanoma

Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy

Screening to identify unsuitable candidates for ipilimumab in advanced melanoma ( Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy )

Nivolumab alone superior to ipilimumab alone in advanced melanoma

Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy

Nivolumab alone superior to ipilimumab alone in advanced melanoma ( Dr Pier Francesco Ferrucci - European Institute of Oncology, Milan, Italy )

Extended adjuvant therapy for HER2-positive early breast cancer

Prof Arlene Chan - The Mount Hospital, Perth, Australia

Extended adjuvant therapy for HER2-positive early breast cancer ( Prof Arlene Chan - The Mount Hospital, Perth, Australia )

New dexamethasone combination yields two-fold improvement in median PFS in...

Prof Meletios Dimopoulos - University of Athens, Athens, Greece

New dexamethasone combination yields two-fold improvement in median PFS in multiple myeloma ( Prof Meletios Dimopoulos - University of Athens, Athens, Greece )

Preliminary analysis on the RNA sequencing data of lung squamous cell carcinoma

Prof Yilong Wu - President of the Chinese Society of Clinical Oncology

Preliminary analysis on the RNA sequencing data of lung squamous cell carcinoma ( Prof Yilong Wu - President of the Chinese Society of Clinical Oncology )

More from ecancer